Healthcare

• Bellberry Human Research Ethics Committee has approved Racura Oncology's HARNESS-1 lung cancer trial.

• The company reported independent preclinical validation of its AlgoraeOS v2 platform.

• The guidance clarifies expectations for medicinal cannabis products supplied into Germany.

• The company plans to launch a security purchase plan targeting up to approximately AUD 1 million.

• Starpharma shares rose 3.52% during the morning session on 3 July 2026 following a collaboration update.

• The company's Xanamem® clinical programme remains the key investor focus.

• Investors continue tracking the company's structural heart valve development programme.